ELUT FY 2020 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$47M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43M-0.5% YoY

Gross Profit

$21M48.2% margin

Operating Income

-$14M-31.9% margin

Net Income

-$22M-51.1% margin

EPS (Diluted)

$-2.13

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$779,000

Balance Sheet

Total Assets

$83M

Total Liabilities

$62M

Stockholders' Equity

$21M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$43M	-0.5%
Gross Profit	$21M	$20M	+4.0%
Operating Income	-$14M	-$8M	-61.7%
Net Income	-$22M	-$12M	-82.8%